Lipidomics-based natural products for chronic kidney disease treatment
Chronic kidney disease (CKD) is by far the most prevalent disease in the world and is now a major global public health problem because of the increase in diabetes, hypertension and obesity. Traditional biomarkers of kidney function lack sensitivity and specificity for early detection and monitoring...
Saved in:
Main Authors: | Rui Zhang, Jingjing Wang, Chenguang Wu, Lifan Wang, Peng Liu, Ping Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024176517 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring therapeutic mechanisms of Chuan Huang Fang-II in the treatment of acute kidney injury on chronic kidney disease patients from the perspective of lipidomics
by: Ling Chen, et al.
Published: (2024-12-01) -
Lipidome disruption in Alzheimer’s disease brain: detection, pathological mechanisms, and therapeutic implications
by: Sijia He, et al.
Published: (2025-01-01) -
Targeted lipidomics analysis of possible molecular mechanisms of lipid changes in temporal lobe epilepsy models
by: Huaiyu Sun, et al.
Published: (2025-01-01) -
The developmental lipidome of Nippostrongylus brasiliensis
by: Tao Wang, et al.
Published: (2025-01-01) -
Effects of different processing methods on the lipid composition of hazelnut oil: A lipidomics analysis
by: Jiayang Sun, et al.
Published: (2022-03-01)